UniProtKB/Swiss-Prot P31040: Variant p.Val333Ile

Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
Gene: SDHA
Feedback?

Variant information Variant position:

333 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Isoleucine (I) at position 333 (V333I, p.Val333Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1062468 [ dbSNP | Ensembl ]

Sequence information Variant position:

333 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

664 The length of the canonical sequence.
Location on the sequence:

GEGGILINSQGERFMERYAP V AKDLASRDVVSRSMTLEIRE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTLEIRE

Mouse                         GEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTLEIRE

Rat                           GEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTLEIRE

Pig                           GEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTLEIRE

Bovine                        GEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTLEIRE

Chicken                       GEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTIEIRE

Xenopus tropicalis            GEGGILINSEGERFMERYAPVAKDLASRDVVSRSMTIEIRE

Zebrafish                     GEGGILINSEGERFMERYAPNAKDLASRDVVSRSMTIEIRE

Caenorhabditis elegans        GEGGYLVNSAGERFMERYAPNAKDLASRDVVSRSMTVEIME

Drosophila                    GEGGYLINGNGERFMERYAPVAKDLASRDVVSRSMTIEIME

Slime mold                    GEGGYLLNSSGERFMPRYAPSVADLASRDVVSRSETMEIRE

Baker's yeast                 GEGGFLVNSEGERFMERYAPTAKDLACRDVVSRAITMEIRE

Fission yeast                 GEGGYLLNSKGERFMERYAPTAKDLASRDVVSRAMTVEIRE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	43 – 664	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
Active site	340 – 340	Proton acceptor
Binding site	340 – 340
Modified residue	335 – 335	N6-acetyllysine; alternate
Modified residue	335 – 335	N6-succinyllysine; alternate
Turn	332 – 334

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.